EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
12.25
-0.61 (-4.74%)
At close: Jul 31, 2026, 4:00 PM EDT
12.24
-0.01 (-0.08%)
After-hours: Jul 31, 2026, 7:34 PM EDT
EyePoint Employees
EyePoint had 214 employees as of December 31, 2025. The number of employees increased by 49 or 29.70% compared to the previous year.
Employees
214
Change (1Y)
49
Growth (1Y)
29.70%
Revenue / Employee
$35,579
Profits / Employee
-$1,269,154
Market Cap
1.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 214 | 49 | 29.70% | 214 | 0 |
| Dec 31, 2024 | 165 | 44 | 36.36% | 165 | 0 |
| Dec 31, 2023 | 121 | -23 | -15.97% | 121 | 0 |
| Dec 31, 2022 | 144 | 21 | 17.07% | 144 | 0 |
| Dec 31, 2021 | 123 | 22 | 21.78% | 122 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Wave Life Sciences | 317 |
| Olema Pharmaceuticals | 137 |
| Alpha Tau Medical | 121 |
| Cullinan Therapeutics | 109 |
| Lexicon Pharmaceuticals | 81 |
| Inventiva | 77 |
| Alto Neuroscience | 68 |
EYPT News
- 2 days ago - EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME) - GlobeNewsWire
- 10 days ago - EyePoint price target lowered to $30 from $33 at JPMorgan - TheFly
- 15 days ago - EyePoint to pay $4.6M to resolve False Claim Act allegations - TheFly
- 16 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - EyePoint initiated with a Buy at Stifel - TheFly
- 19 days ago - EyePoint appoints Tarek Hassan as chief strategic science officer - TheFly
- 19 days ago - EyePoint Appoints Tarek S. Hassan, M.D. - GlobeNewsWire
- 24 days ago - EyePoint assumed with an Overweight at Cantor Fitzgerald - TheFly